Stockreport

Angle PLC Announces Study of Ovarian Cancer CTCs Using Parsortix [Yahoo! Finance]

ANGLE PLC S/ADR  (ANPCY) 
PDF The study investigated 123 metastatic ovarian cancer patients over two and a half years using the Parsortix system to assess 474 longitudinal patient samples Downstre [Read more]